We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

81 hedge funds and large institutions have $145M invested in Immunomedics Inc in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 25 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 25

4% less call options, than puts

Call options by funds: $11.8M | Put options by funds: $12.3M

2% less funds holding

Funds holding: 8381 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

30% less capital invested

Capital invested by funds: $208M → $145M (-$63.1M)

Holders
81
Holders Change
-2
Holders Change %
-2.41%
% of All Funds
2.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
31
Reduced
25
Closed
10
Calls
$11.8M
Puts
$12.3M
Net Calls
-$535K
Net Calls Change
-$5.69M
Name Holding Trade Value Shares
Change
Change in
Stake
Prudential Financial
26
Prudential Financial
New Jersey
$527K +$510K +114,523 New
TA
27
Teachers Advisors
New York
$517K +$58.2K +13,068 +13%
Morgan Stanley
28
Morgan Stanley
New York
$488K +$184K +41,398 +64%
State Board of Administration of Florida Retirement System
29
State Board of Administration of Florida Retirement System
Florida
$473K
Allianz Asset Management
30
Allianz Asset Management
Germany
$460K
AllianceBernstein
31
AllianceBernstein
Tennessee
$460K +$2.23K +500 +0.5%
Millennium Management
32
Millennium Management
New York
$439K +$191K +42,844 +82%
CS
33
Credit Suisse
Switzerland
$431K -$375K -84,105 -47%
OC
34
Oppenheimer & Co
New York
$398K +$81K +18,200 +27%
Goldman Sachs
35
Goldman Sachs
New York
$362K +$234K +52,573 +203%
Swiss National Bank
36
Swiss National Bank
Switzerland
$313K
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$311K -$7.12K -1,600 -2%
DTL
38
Dynamic Technology Lab
Singapore
$295K +$207K +46,526 +265%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$284K
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$282K
NFA
41
Nationwide Fund Advisors
Ohio
$262K -$50.6K -11,355 -17%
AQR Capital Management
42
AQR Capital Management
Connecticut
$259K
BA
43
BlackRock Advisors
Delaware
$233K +$20K +4,499 +10%
AIG
44
American International Group
New York
$224K -$2.17K -488 -1%
Public Employees Retirement Association of Colorado
45
Public Employees Retirement Association of Colorado
Colorado
$221K
Jane Street
46
Jane Street
New York
$212K +$205K +46,098 New
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$196K +$4.45K +1,000 +2%
Citigroup
48
Citigroup
New York
$194K +$49.8K +11,194 +36%
ProShare Advisors
49
ProShare Advisors
Maryland
$193K -$149K -33,500 -44%
BG
50
BlackRock Group
United Kingdom
$158K +$70.8K +15,899 +86%

IMMU Hedge Fund Activity: Q4 2013 in Review

81 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2013, worth a combined $145M — down 30% from $208M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IMMU and 8 opened new positions — a net loss of 2 holders — while 25 trimmed existing stakes and 31 added.

The largest buyer was Susquehanna International Group, adding an estimated $1.44M. The largest seller was Sigma Capital Management, cutting an estimated $5.45M.

  • 81 institutional investors held Immunomedics Inc (IMMU) as of Q4 2013, down from 83 in Q3 2013.
  • Funds reported $145M of Immunomedics Inc stock for Q4 2013, down 30% quarter-over-quarter.
  • 8 funds opened new Immunomedics Inc positions in Q4 2013 and 10 closed out, a net change of -2 holders.
  • The largest Immunomedics Inc buyer in Q4 2013 was Susquehanna International Group, an estimated $1.44M added.
  • The largest Immunomedics Inc seller in Q4 2013 was Sigma Capital Management, an estimated $5.45M sold.

Based on aggregated 13F filings for Q4 2013.